• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Obesity and coronary artery calcium in diabetes: the Coronary Artery Calcification in Type 1 Diabetes (CACTI) study.糖尿病与冠状动脉钙:1 型糖尿病冠状动脉钙化研究(CACTI)。
Diabetes Technol Ther. 2011 Oct;13(10):991-6. doi: 10.1089/dia.2011.0046. Epub 2011 Jul 19.
2
Reduced heart rate variability predicts progression of coronary artery calcification in adults with type 1 diabetes and controls without diabetes.心率变异性降低可预测 1 型糖尿病成人及无糖尿病对照者冠状动脉钙化进展。
Diabetes Technol Ther. 2010 Dec;12(12):963-9. doi: 10.1089/dia.2010.0070.
3
Progression of coronary artery calcium in type 1 diabetes mellitus.1型糖尿病患者冠状动脉钙化的进展
Am J Cardiol. 2007 Nov 15;100(10):1543-7. doi: 10.1016/j.amjcard.2007.06.050. Epub 2007 Sep 27.
4
The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium.通过冠状动脉钙化评估的代谢综合征、糖尿病和亚临床动脉粥样硬化。
J Am Coll Cardiol. 2003 May 7;41(9):1547-53. doi: 10.1016/s0735-1097(03)00193-1.
5
A prospective study of abdominal obesity and coronary artery calcium progression in older adults.一项针对老年人腹部肥胖与冠状动脉钙进展的前瞻性研究。
J Clin Endocrinol Metab. 2009 Dec;94(12):5039-44. doi: 10.1210/jc.2009-1497. Epub 2009 Oct 21.
6
Longitudinal Associations of Healthy Dietary Pattern Scores with Coronary Artery Calcification and Pericardial Adiposity in United States Adults with and without Type 1 Diabetes.美国 1 型和 2 型糖尿病患者健康饮食模式评分与冠状动脉钙化和心包脂肪的纵向关联。
J Nutr. 2023 Jul;153(7):2085-2093. doi: 10.1016/j.tjnut.2023.05.016. Epub 2023 May 13.
7
Plasma triglycerides predict incident albuminuria and progression of coronary artery calcification in adults with type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes Study.血浆甘油三酯可预测1型糖尿病成人患者蛋白尿的发生及冠状动脉钙化进展:1型糖尿病冠状动脉钙化研究
J Clin Lipidol. 2014 Nov-Dec;8(6):576-583. doi: 10.1016/j.jacl.2014.08.008. Epub 2014 Aug 30.
8
Greater progression of coronary artery calcification is associated with clinically relevant cognitive impairment in type 1 diabetes.1 型糖尿病患者冠状动脉钙化进展与临床相关认知功能障碍相关。
Atherosclerosis. 2019 Jan;280:58-65. doi: 10.1016/j.atherosclerosis.2018.11.003. Epub 2018 Nov 8.
9
Impact of obesity on coronary artery calcification examined by electron beam computed tomographic scan.通过电子束计算机断层扫描检查肥胖对冠状动脉钙化的影响。
Diabetes Obes Metab. 2007 May;9(3):354-9. doi: 10.1111/j.1463-1326.2006.00617.x.
10
Different Metabolic Phenotypes of Obesity and Risk of Coronary Artery Calcium Progression and Incident Cardiovascular Disease Events: The CARDIA Study.肥胖的不同代谢表型与冠状动脉钙化进展及心血管疾病事件发生风险:CARDIA研究
Arterioscler Thromb Vasc Biol. 2022 May;42(5):677-688. doi: 10.1161/ATVBAHA.122.317526. Epub 2022 Apr 7.

引用本文的文献

1
Drawing lines in the sand: The growing threat of obesity in type 1 diabetes.划清界限:1型糖尿病中肥胖日益增长的威胁。
World J Diabetes. 2024 May 15;15(5):823-827. doi: 10.4239/wjd.v15.i5.823.
2
Screening for Subclinical Atherosclerosis and the Prediction of Cardiovascular Events in People with Type 1 Diabetes.1型糖尿病患者亚临床动脉粥样硬化的筛查及心血管事件的预测
J Clin Med. 2024 Feb 15;13(4):1097. doi: 10.3390/jcm13041097.
3
Carbohydrate counting as a strategy to optimize glycemic control in type 1 diabetes mellitus.碳水化合物计数作为优化 1 型糖尿病患者血糖控制的策略。
Arch Endocrinol Metab. 2023 Mar 30;67(3):385-394. doi: 10.20945/2359-3997000000596. Epub 2023 Feb 7.
4
The Relationship between Selected Inflammation and Oxidative Stress Biomarkers and Carotid Intima-Media Thickness (IMT) Value in Youth with Type 1 Diabetes Co-Existing with Early Microvascular Complications.1型糖尿病合并早期微血管并发症青年患者中选定的炎症和氧化应激生物标志物与颈动脉内膜中层厚度(IMT)值之间的关系
J Clin Med. 2022 Aug 13;11(16):4732. doi: 10.3390/jcm11164732.
5
Obesity in Patients with Type 1 Diabetes: Links, Risks and Management Challenges.1型糖尿病患者的肥胖:关联、风险及管理挑战
Diabetes Metab Syndr Obes. 2021 Jun 21;14:2807-2827. doi: 10.2147/DMSO.S223618. eCollection 2021.
6
Nutrition and Obesity in the Pathogenesis of Youth-Onset Type 1 Diabetes and Its Complications.营养与肥胖在青年起病 1 型糖尿病及其并发症发病机制中的作用。
Front Endocrinol (Lausanne). 2021 Mar 22;12:622901. doi: 10.3389/fendo.2021.622901. eCollection 2021.
7
Non-Insulin Antidiabetes Treatment in Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis.1 型糖尿病中非胰岛素抗糖尿病治疗:系统评价和荟萃分析。
Diabetes Metab J. 2021 May;45(3):312-325. doi: 10.4093/dmj.2020.0171. Epub 2021 Mar 15.
8
Association of apolipoprotein C3 with insulin resistance and coronary artery calcium in patients with type 1 diabetes.载脂蛋白 C3 与 1 型糖尿病患者胰岛素抵抗和冠状动脉钙的关系。
J Clin Lipidol. 2021 Jan-Feb;15(1):235-242. doi: 10.1016/j.jacl.2020.10.006. Epub 2020 Oct 31.
9
Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report.成人糖尿病或糖尿病前期的营养治疗:共识报告。
Diabetes Care. 2019 May;42(5):731-754. doi: 10.2337/dci19-0014. Epub 2019 Apr 18.
10
Management of Asymptomatic Patients With Positive Coronary Artery Calcium Scans.无症状冠状动脉钙化扫描阳性患者的管理
J Endocr Soc. 2017 Jun 1;1(6):588-599. doi: 10.1210/js.2016-1080.

本文引用的文献

1
Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes.代谢综合征作为1型糖尿病患者心血管疾病、死亡率及糖尿病肾病进展的危险因素。
Diabetes Care. 2009 May;32(5):950-2. doi: 10.2337/dc08-2022. Epub 2009 Feb 5.
2
Association between body mass index and core components of metabolic syndrome in 1486 patients with type 1 diabetes mellitus in Japan (JDDM 13).日本1486例1型糖尿病患者(JDDM 13)的体重指数与代谢综合征核心组分之间的关联
Endocr J. 2008 Dec;55(6):1025-32. doi: 10.1507/endocrj.k08e-167. Epub 2008 Aug 28.
3
The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).无心血管代谢危险因素聚集的肥胖人群与有心血管代谢危险因素聚集的正常体重人群:美国人群(1999 - 2004年美国国家健康与营养检查调查)中两种表型的患病率及其相关因素
Arch Intern Med. 2008 Aug 11;168(15):1617-24. doi: 10.1001/archinte.168.15.1617.
4
Progression of coronary artery calcium in type 1 diabetes mellitus.1型糖尿病患者冠状动脉钙化的进展
Am J Cardiol. 2007 Nov 15;100(10):1543-7. doi: 10.1016/j.amjcard.2007.06.050. Epub 2007 Sep 27.
5
Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications Trial.1型糖尿病中的胰岛素抵抗、代谢综合征及并发症风险:糖尿病控制与并发症试验中的“双重糖尿病”
Diabetes Care. 2007 Mar;30(3):707-12. doi: 10.2337/dc06-1982.
6
The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate: the Pittsburgh Epidemiology of Diabetes Complications Study experience.1型糖尿病主要结局的预测:对代谢综合征的三种不同定义及其组成部分以及估计的葡萄糖处置率进行的12年前瞻性评估:匹兹堡糖尿病并发症流行病学研究经验
Diabetes Care. 2007 May;30(5):1248-54. doi: 10.2337/dc06-2053. Epub 2007 Feb 15.
7
The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men.腰围在代谢综合征定义中的重要性:男性死亡率的前瞻性分析
Diabetes Care. 2006 Feb;29(2):404-9. doi: 10.2337/diacare.29.02.06.dc05-1636.
8
Insulin resistance syndrome, body mass index and the risk of ischemic heart disease.胰岛素抵抗综合征、体重指数与缺血性心脏病风险
CMAJ. 2005 May 10;172(10):1301-5. doi: 10.1503/cmaj.1040834.
9
Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial.糖尿病控制与并发症试验中强化血糖控制对1型糖尿病炎症标志物水平的影响。
Circulation. 2005 May 17;111(19):2446-53. doi: 10.1161/01.CIR.0000165064.31505.3B. Epub 2005 May 2.
10
Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.1999 - 2002年美国儿童、青少年及成年人中超重和肥胖的患病率
JAMA. 2004 Jun 16;291(23):2847-50. doi: 10.1001/jama.291.23.2847.

糖尿病与冠状动脉钙:1 型糖尿病冠状动脉钙化研究(CACTI)。

Obesity and coronary artery calcium in diabetes: the Coronary Artery Calcification in Type 1 Diabetes (CACTI) study.

机构信息

Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado 80045, USA.

出版信息

Diabetes Technol Ther. 2011 Oct;13(10):991-6. doi: 10.1089/dia.2011.0046. Epub 2011 Jul 19.

DOI:10.1089/dia.2011.0046
PMID:21770813
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3182677/
Abstract

BACKGROUND

The aim was to examine whether excess weight is associated with coronary artery calcium (CAC), independent of metabolic parameters in adults with type 1 diabetes (T1D).

METHODS

Subjects between 19 and 56 years of age with T1D (n=621) from the Coronary Artery Calcification in Type 1 Diabetes study were classified as abnormal on four metabolic parameters: blood pressure ≥130/85 mm Hg or on antihypertensive treatment; high-density lipoprotein-cholesterol of <40 mg/dL for men or <50 mg/dL for women; triglycerides of ≥150 mg/dL; or C-reactive protein of ≥3 μg/mL. Study participants with two or more abnormal parameters were classified as metabolically abnormal. Weight categories by body mass index were normal (<25 kg/m(2)), overweight (25 to <30 kg/m(2)), and obese (≥30 kg/m(2)). CAC was measured at two visits 6.0±0.5 years apart. Progression of CAC was defined as an increase in square root transformed CAC volume of ≥2.5 mm(3) or development of clinical coronary artery disease.

RESULTS

Among subjects with T1D, 48% of normal, 61% of overweight, and 73% of obese participants were classified as metabolically abnormal (P<0.0001). Overweight and obesity were independently associated with presence of CAC, independent of presence of metabolically abnormal. Obesity but not overweight was associated with CAC progression, independent of the other cardiovascular risk factors.

CONCLUSIONS

Although obesity is known to increase cardiovascular disease risk through inducing metabolic abnormalities such as dyslipidemia, hypertension, and inflammation, it is also a strong predictor of subclinical atherosclerosis progression in adults with T1D independent of these factors.

摘要

背景

本研究旨在探讨超重是否与 1 型糖尿病(T1D)成人的冠状动脉钙(CAC)有关,而不考虑代谢参数。

方法

来自 1 型糖尿病冠状动脉钙化研究(Coronary Artery Calcification in Type 1 Diabetes study)的年龄在 19 至 56 岁之间的 T1D 患者(n=621),如果存在以下 4 种代谢参数异常,则被归类为异常:血压≥130/85mmHg 或正在接受降压治疗;男性高密度脂蛋白胆固醇<40mg/dL,女性<50mg/dL;甘油三酯≥150mg/dL;或 C 反应蛋白≥3μg/mL。如果研究参与者存在两种或两种以上异常参数,则被归类为代谢异常。根据体重指数,体重类别分为正常(<25kg/m2)、超重(25 至<30kg/m2)和肥胖(≥30kg/m2)。在两次就诊中测量 CAC,两次就诊时间间隔 6.0±0.5 年。CAC 的进展定义为平方根转换的 CAC 体积增加≥2.5mm3 或临床冠心病的发生。

结果

在 T1D 患者中,48%的正常体重、61%的超重和 73%的肥胖患者被归类为代谢异常(P<0.0001)。超重和肥胖与 CAC 的存在独立相关,与代谢异常的存在无关。肥胖但不超重与 CAC 进展相关,与其他心血管危险因素无关。

结论

虽然肥胖通过诱导血脂异常、高血压和炎症等代谢异常增加心血管疾病风险,但它也是 T1D 成人亚临床动脉粥样硬化进展的一个强有力的预测因素,与这些因素无关。